Certara (CERT) Q1 2026 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool

Mon, May 11, 2026 astatine 12:32 PM CDT 48 min read

Image source: The Motley Fool.

DATE

Monday, May 11, 2026 astatine 8:30 a.m. ET

CALL PARTICIPANTS

• Chief Executive Officer — Jon Resnick

• Chief Financial Officer — John Gallagher

• Operator

Full Conference Call Transcript

Jon Resnick: Good morning. Thank you each for joining today's call. Since we past spoke, I person crossed implicit the 100-day people astatine Certara, and I proceed to beryllium incredibly impressed by galore things wrong the company. We are differentiated by our world-leading scientists, organization knowledge, regulatory enactment and our fit-for-purpose exertion that is embedded successful lawsuit and regulators' workflows. Our objective quality capableness is the logic built into our technology, mining the latest subject and drafting connected what our experts know, our interactions with regulators implicit decades and what thousands of cause improvement successes and failures person taught us. Certara products and services are integral to the cause improvement process and progressively scalable done the usage of AI technologies.

Having exited the listening and learning phase, my attraction has transitioned to helping Certara scope its afloat potential. First 4th show was successful enactment with our expectations, but does not bespeak the company's potential. I americium focused connected driving semipermanent durable maturation crossed the enactment by reshaping our concern and portfolio strategy portion instilling accrued organizational and operational rigor. Today, we volition sermon our markets and outline the steps we are taking to presumption the institution for semipermanent occurrence earlier wrapping up with our archetypal 4th performance. Let maine commencement by updating you connected our extremity markets. Across the board, customers are expanding concern successful AI and tech-enabled cause find capabilities.

Today, determination are implicit 200 AI designed molecules successful objective development, up from conscionable a fewer 10 years ago. Eli Lilly has partnered with NVIDIA to physique a dedicated AI lab, and Roche Genentech is launching a hybrid unreality AI mill to standard their find and improvement efforts. Amazon has besides announced the Bio Discovery merchandise done AWS. Additionally, OpenAI and Anthropic person announced LLMs for beingness science. The enlargement of the usage lawsuit successful AI is accordant with Certara's attack utilizing analytical techniques embedded successful customers' workflow to accelerate the cause find and improvement processes portion reducing the reliance connected surviving subjects.

As AI-driven cause improvement helps the manufacture present much molecules and innovation, request volition summation for Certara's halfway business, Model-informed cause development, oregon MIDD, arsenic customers contention to crook cause candidates into approved treatments for patients. Accelerating information analytics processes becomes much important than ever arsenic the decades-long extremity of reducing cause exertion timeline comes wrong reach. In February, the ICH released ICH M15, providing guidance of the wide principles for model-informed cause improvement which establishes an overarching acceptable of principles for the acceptance of MIDD applications by regulators globally. In March, the FDA published guidance connected the wide information for the usage of caller attack methodologies oregon NAMs successful cause development.